Search details
1.
Clostridioides difficile infections; new treatments and future perspectives.
Curr Opin Gastroenterol
; 40(1): 7-13, 2024 01 01.
Article
in English
| MEDLINE | ID: mdl-37942659
2.
Can SARS-CoV-2 be transmitted via faeces?
Curr Opin Gastroenterol
; 38(1): 26-29, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-34628417
3.
The potential of microbiome replacement therapies for Clostridium difficile infection.
Curr Opin Gastroenterol
; 38(1): 1-6, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-34871192
4.
Eravacycline, a novel tetracycline derivative, does not induce Clostridioides difficile infection in an in vitro human gut model.
J Antimicrob Chemother
; 76(1): 171-178, 2021 01 01.
Article
in English
| MEDLINE | ID: mdl-32929459
5.
The use of first-generation cephalosporin antibiotics, cefalexin and cefradine, is not associated with induction of simulated Clostridioides difficile infection.
J Antimicrob Chemother
; 77(1): 148-154, 2021 12 24.
Article
in English
| MEDLINE | ID: mdl-34561709
6.
Is there a causal relationship between trehalose consumption and Clostridioides difficile infection?
Curr Opin Gastroenterol
; 37(1): 9-14, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33105252
7.
Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon.
BMC Microbiol
; 20(1): 2, 2020 01 02.
Article
in English
| MEDLINE | ID: mdl-31898476
8.
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon.
Antimicrob Agents Chemother
; 63(2)2019 02.
Article
in English
| MEDLINE | ID: mdl-30455242
9.
Editorial: The fight against infectious diseases begins anew.
Curr Opin Gastroenterol
; 39(1): 1-2, 2023 Jan 01.
Article
in English
| MEDLINE | ID: mdl-36504029
10.
Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.
Antimicrob Agents Chemother
; 60(2): 968-81, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26643348
11.
Comprehensive assignment of roles for Salmonella typhimurium genes in intestinal colonization of food-producing animals.
PLoS Genet
; 9(4): e1003456, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23637626
12.
The post-translational modification of the Clostridium difficile flagellin affects motility, cell surface properties and virulence.
Mol Microbiol
; 94(2): 272-89, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25135277
13.
The HtrA-like protease CD3284 modulates virulence of Clostridium difficile.
Infect Immun
; 82(10): 4222-32, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-25047848
14.
The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile.
PLoS Pathog
; 7(10): e1002317, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-22022270
15.
MiGut: A scalable in vitro platform for simulating the human gut microbiome-Development, validation and simulation of antibiotic-induced dysbiosis.
Microb Biotechnol
; 16(6): 1312-1324, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37035991
16.
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota.
Front Microbiol
; 13: 901911, 2022.
Article
in English
| MEDLINE | ID: mdl-35711781
17.
Trehalose-Induced Remodelling of the Human Microbiota Affects Clostridioides difficile Infection Outcome in an In Vitro Colonic Model: A Pilot Study.
Front Cell Infect Microbiol
; 11: 670935, 2021.
Article
in English
| MEDLINE | ID: mdl-34277467
18.
Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection.
NPJ Biofilms Microbiomes
; 7(1): 16, 2021 02 05.
Article
in English
| MEDLINE | ID: mdl-33547298
19.
A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent Clostridioides difficile Infection in Pre-clinical Models.
Front Microbiol
; 11: 578903, 2020.
Article
in English
| MEDLINE | ID: mdl-33072047
20.
Clostridium difficile trehalose metabolism variants are common and not associated with adverse patient outcomes when variably present in the same lineage.
EBioMedicine
; 43: 347-355, 2019 May.
Article
in English
| MEDLINE | ID: mdl-31036529